Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-13
1992-07-07
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514399, 514400, 514 94, 514252, 5142355, 5142358, A61K 3141, A61K 31415
Patent
active
051283557
ABSTRACT:
Substituted imidazoles such as ##STR1## are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4301169 (1981-11-01), Yamanaka et al.
patent: 4328349 (1982-05-01), Grayboyes et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4347364 (1982-08-01), Walser et al.
patent: 4347365 (1982-08-01), Walser et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4379927 (1983-04-01), Vorbruggen et al.
patent: 4402966 (1983-09-01), Yamanaka et al.
patent: 4435395 (1984-03-01), Loev et al.
patent: 4448781 (1984-05-01), Cross et al.
patent: 4463011 (1984-07-01), Ogata
patent: 4532331 (1985-07-01), Frazee et al.
patent: 4533669 (1985-08-01), Yamanaka et al.
patent: 4539322 (1985-09-01), Campbell et al.
patent: 4602031 (1986-07-01), Yamanaka et al.
patent: 4689182 (1987-08-01), Rafferty
patent: 4755518 (1988-07-01), Rafferty
Wong et al., Abstract No. 30, Hypertension, p. 340, vol. 12, No. 3, Sep. 1988, High Blood Pressure Council Mtg., San Francisco, Calif., Sep. 28-Oct. 1, 1988, "X-6803 Methyl-2-N-Butyl-1-(4-(2-Carboxybenzamido)Benzyl-4-Chloroimidazole-5-Aceta te, Sodium Salt): A Novel Noneptide Angiotensin II Receptor Antagonist".
Chiu et al., Abstract No. 118.11, The Pharmacologist, vol. 30, p. A165, 1988, for ASPET Mtg., Montreal, Canada, Oct. 9-13, 1988: "Nonpeptide Angiotensin II (AII) Receptor Antagonists: Structure Function Studies".
Wong et al., Nonpeptide Angiotensin II Receptor Antagonists, I Pharmacological Characterization of 2-n-Butyl-Chloro-1(2-chlorobenzyl)imidazole-5-acetic Acid, Sodium Salt (S-8307), "J. Pharmacology and Experimental Therapeutics," vol. 247, No. 1, pp. 1-7 (1988).
Chiu et al., "Non-Peptide Angiotensin II Receptor Antagonists, II, Pharmacology of S-8303," European Journal of Pharmacology, vol. 157, pp. 13-21 (1988).
Lindgren et al., Eur. J. Pharmacol., 135:383, 1987.
Schmidt et al., J. Cardiovascular Pharmacology, vol. 8, pp. S100-105, 1986.
H. Torii, Takeda Kenkyusshoho, 40, No. 3/4, 180-191 (1982).
Pals et al., Circulation Research, 29, 673 (1971).
Streeten and Anderson, Handbook of Hypertension, vol. 5, Clinical Pharmogy of Antihypertensive Drugs, A. E. Doyle (Editor), Elsevier Science Publishers B. V., p. 246 (1984).
Satoh et al., Cir. Res., 36/37 & Suppl. I: I-89, 1975.
Carini David J.
Duncia John J. V.
E. I. Du Pont de Nemours and Company
Gardner Diane
Waddell Frederick E.
LandOfFree
Treatment of congestive heart failure with angiotensin 11 recept does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of congestive heart failure with angiotensin 11 recept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of congestive heart failure with angiotensin 11 recept will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1830086